Mišković, D.; Mraz, N.; Radovani Trbojević, B.; Jurin, I.; Đanić Hadžibegović, A.; Gudelj, I.; Lauc, G.; Hadžibegović, I.
IgG N-Glycosylation During Atorvastatin Therapy After Acute Coronary Syndrome is Associated with LDL Cholesterol Reduction. J. Clin. Med. 2026, 15, 3056.
https://doi.org/10.3390/jcm15083056
AMA Style
Mišković D, Mraz N, Radovani Trbojević B, Jurin I, Đanić Hadžibegović A, Gudelj I, Lauc G, Hadžibegović I.
IgG N-Glycosylation During Atorvastatin Therapy After Acute Coronary Syndrome is Associated with LDL Cholesterol Reduction. Journal of Clinical Medicine. 2026; 15(8):3056.
https://doi.org/10.3390/jcm15083056
Chicago/Turabian Style
Mišković, Domagoj, Nikol Mraz, Barbara Radovani Trbojević, Ivana Jurin, Ana Đanić Hadžibegović, Ivan Gudelj, Gordan Lauc, and Irzal Hadžibegović.
2026. "IgG N-Glycosylation During Atorvastatin Therapy After Acute Coronary Syndrome is Associated with LDL Cholesterol Reduction" Journal of Clinical Medicine 15, no. 8: 3056.
https://doi.org/10.3390/jcm15083056
APA Style
Mišković, D., Mraz, N., Radovani Trbojević, B., Jurin, I., Đanić Hadžibegović, A., Gudelj, I., Lauc, G., & Hadžibegović, I.
(2026). IgG N-Glycosylation During Atorvastatin Therapy After Acute Coronary Syndrome is Associated with LDL Cholesterol Reduction. Journal of Clinical Medicine, 15(8), 3056.
https://doi.org/10.3390/jcm15083056
